White label – Pompe disease - ClinicalTrials.eu

Study Comparing Romiplostim and Dexamethasone with Dexamethasone Alone for Patients with Newly Diagnosed Primary Immune Thrombocytopenia

Not recruiting

3 1 1 1
Investigated Diseases:
- Immune thrombocytopenia
Investigated Drugs:
- Romiplostim
- Dexamethasone Phosphate
Study on Golcadomide and R-CHOP Drug Combination for Patients with Untreated High-risk Large B-cell Lymphoma

Not recruiting

3 1 1
Investigated Drugs:
+11
Study of Atezolizumab and Chemotherapy for Patients with Non-Resectable Non-Small Cell Lung Cancer

Not recruiting

2 1 1 1
Investigated Diseases:
- Non-small cell lung cancer
Investigated Drugs:
- Atezolizumab
Study on the Safety of Tirbanibulin and Diclofenac Sodium for Adults with Actinic Keratosis on the Face or Scalp

Not recruiting

3 1 1 1
Investigated Drugs:
- Tirbanibulin
- Diclofenac Sodium
Study of ribociclib combined with hormone therapy for patients with early-stage hormone receptor-positive, HER2-negative breast cancer

Not recruiting

3 1 1 1
Investigated Diseases:
- Breast cancer
- Hormone receptor positive breast cancer
Investigated Drugs:
+4
Study on the Safety and Effectiveness of Zilucoplan Auto-Injector for Adults with Generalized Myasthenia Gravis

Not recruiting

3 1 1
Investigated Diseases:
- Myasthenia gravis
Investigated Drugs:
- Zilucoplan Sodium
Study on Batoclimab for Patients with Thyroid Eye Disease

Not recruiting

3 1 1
Investigated Diseases:
- Endocrine ophthalmopathy
Investigated Drugs:
- Batoclimab
+1
Study of Vorasidenib for Patients with Residual or Recurrent Grade 2 Glioma with IDH1 or IDH2 Mutation

Not recruiting

3 1
Investigated Diseases:
- Glioma
Investigated Drugs:
- Vorasidenib
Study on Preserving the Voice Box in Patients with Advanced Laryngeal or Hypopharyngeal Cancer Using Cisplatin, Fluorouracil, and Docetaxel Therapy

Not recruiting

3 1 1 1
Investigated Diseases:
- Laryngeal squamous cell carcinoma
- Squamous cell carcinoma of the hypopharynx
Investigated Drugs:
Study of Futibatinib and Pembrolizumab for Patients with Advanced or Metastatic Bladder, Urethra, or Pelvis Cancer Not Suitable for Platinum Treatment

Not recruiting

2 1 1 1
Investigated Diseases:
- Transitional cell carcinoma recurrent
- Transitional cell carcinoma
Investigated Drugs:
- Futibatinib
- Pembrolizumab

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies